These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The identification of a TNBC liver metastasis gene signature by sequential CTC-xenograft modeling. Vishnoi M; Liu NH; Yin W; Boral D; Scamardo A; Hong D; Marchetti D Mol Oncol; 2019 Sep; 13(9):1913-1926. PubMed ID: 31216110 [TBL] [Abstract][Full Text] [Related]
5. Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment. Messaritakis I; Nikolaou M; Koinis F; Politaki E; Koutsopoulos A; Lagoudaki E; Vetsika EK; Georgoulias V; Kotsakis A Lung Cancer; 2019 Sep; 135():33-39. PubMed ID: 31447000 [TBL] [Abstract][Full Text] [Related]
6. Brief report on the clinical characteristics of patients whose samples generate small cell lung cancer circulating tumour cell derived explants. Vickers AJ; Frese K; Galvin M; Carter M; Franklin L; Morris K; Pierce J; Descamps T; Blackhall F; Dive C; Carter L Lung Cancer; 2020 Dec; 150():216-220. PubMed ID: 33221678 [TBL] [Abstract][Full Text] [Related]
7. MUC1 and CD147 Are Promising Markers for the Detection of Circulating Tumor Cells in Small Cell Lung Cancer. Savarese-Brenner B; Heugl M; Rath B; Schweizer C; Obermayr E; Stickler S; Hamilton G Anticancer Res; 2022 Jan; 42(1):429-439. PubMed ID: 34969753 [TBL] [Abstract][Full Text] [Related]
8. Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells. Su Z; Wang Z; Ni X; Duan J; Gao Y; Zhuo M; Li R; Zhao J; Ma Q; Bai H; Chen H; Wang S; Chen X; An T; Wang Y; Tian Y; Yu J; Wang D; Xie XS; Bai F; Wang J Clin Cancer Res; 2019 Aug; 25(16):5049-5060. PubMed ID: 31113842 [TBL] [Abstract][Full Text] [Related]
9. [Establishment of A Patient-derived Xenotransplantation Animal Model for Small Cell Lung Cancer and Drug Resistance Model]. Zhu Y; Huang W; Wu Y; Jia L; Li Y; Chen R; Guo L; Chen Q Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):6-14. PubMed ID: 30674387 [TBL] [Abstract][Full Text] [Related]
10. Predictive and prognostic value of folate receptor-positive circulating tumor cells in small cell lung cancer patients treated with first-line chemotherapy. Shen J; Zhao J; Jiang T; Li X; Zhao C; Su C; Zhou C Oncotarget; 2017 Jul; 8(30):49044-49052. PubMed ID: 28467771 [TBL] [Abstract][Full Text] [Related]
11. Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer. Stewart CA; Gay CM; Xi Y; Sivajothi S; Sivakamasundari V; Fujimoto J; Bolisetty M; Hartsfield PM; Balasubramaniyan V; Chalishazar MD; Moran C; Kalhor N; Stewart J; Tran H; Swisher SG; Roth JA; Zhang J; de Groot J; Glisson B; Oliver TG; Heymach JV; Wistuba I; Robson P; Wang J; Byers LA Nat Cancer; 2020 Apr; 1():423-436. PubMed ID: 33521652 [TBL] [Abstract][Full Text] [Related]
14. Will liquid biopsies improve outcomes for patients with small-cell lung cancer? Blackhall F; Frese KK; Simpson K; Kilgour E; Brady G; Dive C Lancet Oncol; 2018 Sep; 19(9):e470-e481. PubMed ID: 30191851 [TBL] [Abstract][Full Text] [Related]
15. Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study. Morrow CJ; Trapani F; Metcalf RL; Bertolini G; Hodgkinson CL; Khandelwal G; Kelly P; Galvin M; Carter L; Simpson KL; Williamson S; Wirth C; Simms N; Frankliln L; Frese KK; Rothwell DG; Nonaka D; Miller CJ; Brady G; Blackhall FH; Dive C Ann Oncol; 2016 Jun; 27(6):1155-1160. PubMed ID: 27013395 [TBL] [Abstract][Full Text] [Related]
16. Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis. Zhu HH; Liu YT; Feng Y; Zhang LN; Zhang TM; Dong GL; Xing PY; Wang HY; Shi YK; Hu XS Thorac Cancer; 2021 Oct; 12(20):2749-2757. PubMed ID: 34423906 [TBL] [Abstract][Full Text] [Related]
17. Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts. Drapkin BJ; George J; Christensen CL; Mino-Kenudson M; Dries R; Sundaresan T; Phat S; Myers DT; Zhong J; Igo P; Hazar-Rethinam MH; Licausi JA; Gomez-Caraballo M; Kem M; Jani KN; Azimi R; Abedpour N; Menon R; Lakis S; Heist RS; Büttner R; Haas S; Sequist LV; Shaw AT; Wong KK; Hata AN; Toner M; Maheswaran S; Haber DA; Peifer M; Dyson N; Thomas RK; Farago AF Cancer Discov; 2018 May; 8(5):600-615. PubMed ID: 29483136 [TBL] [Abstract][Full Text] [Related]
18. The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer. Lallo A; Frese KK; Morrow CJ; Sloane R; Gulati S; Schenk MW; Trapani F; Simms N; Galvin M; Brown S; Hodgkinson CL; Priest L; Hughes A; Lai Z; Cadogan E; Khandelwal G; Simpson KL; Miller C; Blackhall F; O'Connor MJ; Dive C Clin Cancer Res; 2018 Oct; 24(20):5153-5164. PubMed ID: 29941481 [No Abstract] [Full Text] [Related]
19. Dual occurrence of ALK G1202R solvent front mutation and small cell lung cancer transformation as resistance mechanisms to second generation ALK inhibitors without prior exposure to crizotinib. Pitfall of solely relying on liquid re-biopsy? Ou SI; Lee TK; Young L; Fernandez-Rocha MY; Pavlick D; Schrock AB; Zhu VW; Milliken J; Ali SM; Gitlitz BJ Lung Cancer; 2017 Apr; 106():110-114. PubMed ID: 28285684 [TBL] [Abstract][Full Text] [Related]
20. Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy. Aggarwal C; Wang X; Ranganathan A; Torigian D; Troxel A; Evans T; Cohen RB; Vaidya B; Rao C; Connelly M; Vachani A; Langer C; Albelda S Lung Cancer; 2017 Oct; 112():118-125. PubMed ID: 29191584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]